Refers to the most severe stage of chronic kidney disease (CKD), at which point the patient's kidney function has severely declined, making them unable to effectively eliminate metabolic waste and excess fluid from the body. Their ability to regulate electrolyte and acid-base balance is also extremely diminished, and renal replacement therapy (such as hemodialysis) is typically required to sustain
Conditions
Interventions
Observation group:None
Sponsors
Gaoxin Branch of the First Affiliated Hospital of Nanchang University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age >=18 years; 2. Had undergone regular maintenance hemodialysis at this center for >=3 months prior to October 1, 2023, with relatively stable medical condition; 3. Possessed complete critical medical records and data for both the baseline period (Q4 2023) and the period following implementation of the management model (January 1, 2024, to December 31, 2025).
Exclusion criteria
Exclusion criteria: 1. Hemodialysis vintage 50%), making effective pre- and post-comparison impossible.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Single-compartment Kt/V;Urea Reduction Ratio;Hemoglobin;Hematocrit;Serum Ferritin;Transferrin Saturation;Weekly Erythropoietin Dose;Serum Calcium;Serum Phosphorus;Intact Parathyroid Hormone;Calcium-Phosphorus Product;Serum Albumin;Prealbumin;C-reactive Protein; | — |
Secondary
| Measure | Time frame |
|---|---|
| All-cause Hospitalization Rate;Total Hospital Days;All-cause Mortality Rate;Cardiovascular Mortality Rate;Core Laboratory Target Achievement Rate; | — |
Countries
China
Contacts
Public ContactWu Feifei
Gaoxin Branch of the First Affiliated Hospital of Nanchang University
Outcome results
None listed